youtube_live
Q3 2026 earnings • released • EPS beat +27.23% • Revenue beat +128.58%
See resultschevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.15
arrow_upward
+0.44%(+0.0094) 1D
Nov 13, 12:19:37 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.14
High
$2.19
Low
$2.01
Mkt. cap
331.74M
Avg. vol.
2.42M
Volume
1.46M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.14
High
$2.19
Low
$2.01
Mkt. cap
331.74M
Avg. vol.
2.42M
Volume
1.46M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Zacks
·
1 day ago
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com